Genetic Associations With Toxicity-related Discontinuation of Aromatase Inhibitor Therapy for Breast Cancer

BACKGROUND: Up to 25% of patients discontinue adjuvant aromatase inhibitor (AI) therapy due to intolerable symptoms. Predictors of which patients will be unable to tolerate these medications have not been defined. We hypothesized that inherited variants in candidate genes are associated with treatme...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Henry, N. Lynn, Skaar, Todd C., Dantzer, Jessica, Li, Lang, Kidwell, Kelley, Gersch, Christina, Nguyen, Anne T., Rae, James M., Desta, Zeruesenay, Oesterreich, Steffi, Philips, Santosh, Carpenter, Janet S., Storniolo, Anna M., Stearns, Vered, Hayes, Daniel F., Flockhart, David A.
Формат: Artigo
Язык:Inglês
Опубликовано: 2013
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3646626/
https://ncbi.nlm.nih.gov/pubmed/23546553
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-013-2504-3
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы